NM_001277115.2:c.12943G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001277115.2(DNAH11):​c.12943G>A​(p.Ala4315Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0322 in 1,613,862 control chromosomes in the GnomAD database, including 1,006 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A4315A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.023 ( 60 hom., cov: 33)
Exomes 𝑓: 0.033 ( 946 hom. )

Consequence

DNAH11
NM_001277115.2 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.720

Publications

11 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017455816).
BP6
Variant 7-21894893-G-A is Benign according to our data. Variant chr7-21894893-G-A is described in ClinVar as Benign. ClinVar VariationId is 178738.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0231 (3516/152254) while in subpopulation NFE AF = 0.0364 (2477/68020). AF 95% confidence interval is 0.0352. There are 60 homozygotes in GnomAd4. There are 1635 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 60 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.12943G>A p.Ala4315Thr missense_variant Exon 79 of 82 ENST00000409508.8 NP_001264044.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.12943G>A p.Ala4315Thr missense_variant Exon 79 of 82 5 NM_001277115.2 ENSP00000475939.1
DNAH11ENST00000479878.1 linkn.314G>A non_coding_transcript_exon_variant Exon 2 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3519
AN:
152136
Hom.:
60
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00688
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0213
Gnomad ASJ
AF:
0.0389
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0201
Gnomad FIN
AF:
0.0107
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0364
Gnomad OTH
AF:
0.0321
GnomAD2 exomes
AF:
0.0239
AC:
5963
AN:
249198
AF XY:
0.0252
show subpopulations
Gnomad AFR exome
AF:
0.00646
Gnomad AMR exome
AF:
0.0118
Gnomad ASJ exome
AF:
0.0349
Gnomad EAS exome
AF:
0.000167
Gnomad FIN exome
AF:
0.0138
Gnomad NFE exome
AF:
0.0358
Gnomad OTH exome
AF:
0.0319
GnomAD4 exome
AF:
0.0332
AC:
48506
AN:
1461608
Hom.:
946
Cov.:
31
AF XY:
0.0328
AC XY:
23866
AN XY:
727082
show subpopulations
African (AFR)
AF:
0.00547
AC:
183
AN:
33480
American (AMR)
AF:
0.0127
AC:
568
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0352
AC:
921
AN:
26134
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0195
AC:
1684
AN:
86248
European-Finnish (FIN)
AF:
0.0148
AC:
789
AN:
53402
Middle Eastern (MID)
AF:
0.0371
AC:
214
AN:
5768
European-Non Finnish (NFE)
AF:
0.0382
AC:
42430
AN:
1111786
Other (OTH)
AF:
0.0284
AC:
1712
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2310
4621
6931
9242
11552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1614
3228
4842
6456
8070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0231
AC:
3516
AN:
152254
Hom.:
60
Cov.:
33
AF XY:
0.0220
AC XY:
1635
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00686
AC:
285
AN:
41544
American (AMR)
AF:
0.0212
AC:
324
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0389
AC:
135
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.0201
AC:
97
AN:
4818
European-Finnish (FIN)
AF:
0.0107
AC:
114
AN:
10616
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0364
AC:
2477
AN:
68020
Other (OTH)
AF:
0.0317
AC:
67
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
168
336
503
671
839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0322
Hom.:
279
Bravo
AF:
0.0234
TwinsUK
AF:
0.0378
AC:
140
ALSPAC
AF:
0.0462
AC:
178
ESP6500AA
AF:
0.00654
AC:
25
ESP6500EA
AF:
0.0356
AC:
294
ExAC
AF:
0.0238
AC:
2883
Asia WGS
AF:
0.00837
AC:
30
AN:
3478
EpiCase
AF:
0.0338
EpiControl
AF:
0.0365

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ala4315Thr in exon 79 of DNAH11: This variant is not expected to have clinical s ignificance because it has been identified in 3.6% (294/8262) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs72658825). -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 03, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
2.0
DANN
Benign
0.085
DEOGEN2
Benign
0.021
.;.;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.0067
N
LIST_S2
Benign
0.77
T;T;T
MetaRNN
Benign
0.0017
T;T;T
MetaSVM
Benign
-0.92
T
PhyloP100
0.72
PrimateAI
Benign
0.22
T
PROVEAN
Benign
2.5
.;N;.
REVEL
Benign
0.018
Sift
Benign
1.0
.;T;.
Vest4
0.037
ClinPred
0.00087
T
GERP RS
2.0
Varity_R
0.040
gMVP
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72658825; hg19: chr7-21934511; COSMIC: COSV107411776; API